Literature DB >> 11267715

Pathophysiology of preeclampsia and the role of serotonin.

A C Bolte1, H P van Geijn, G A Dekker.   

Abstract

Hypertensive disorders constitute the most common medical complications of pregnancy. In normal pregnancy, impressive physiological changes take place in the maternal cardiovascular system. Morphological changes are the result of invasion of migratory trophoblast cells into the walls of the spiral arteries. After destruction of elastic, muscular and neural tissue in the media, the trophoblast cells get incorporated into the vessel wall and the endothelial lining of the spiral arteries is restored. The physiological changes create a low-resistance, low-pressure, high-flow system with the absence of maternal vasomotor control. Biochemical adaptations in maternal vasculature include changes in the prostaglandin system, the renin-angiotensin-aldosteron system and the kallikrein-kinin system. In preeclampsia, physiological changes in the spiral arteries are confined to the decidual portion of the arteries. Myometrial segments remain anatomically intact and fail to dilate. In addition, the adrenergic nerve supply is left intact. The cause of this impaired endovascular trophoblast invasion is not yet elucidated. But in combination with the imbalance between vasodilator and vasoconstrictor eicosanoids, it gives rise to reduced perfusion of the intervillous space. In the absence of an adequate production of antiaggregatory prostacyclin (PGI(2)), nitric oxide, or both, surface-mediated platelet activation is supposed to occur on the surface of the spiral arteries. Because platelets are the principal source of circulating serotonin, the increased platelet aggregation in preeclampsia causes an increase in serotonin levels. Interaction of serotonin with serotonin(1)- or serotonin(2)-receptors depends on the state of the endovascular trophoblast or endothelium in the spiral arteries and has opposite effects with regard to vasodilating and vasoconstrictive influences.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11267715     DOI: 10.1016/s0301-2115(00)00367-5

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  23 in total

Review 1.  The Placenta as a Mediator of Stress Effects on Neurodevelopmental Reprogramming.

Authors:  Stefanie L Bronson; Tracy L Bale
Journal:  Neuropsychopharmacology       Date:  2015-08-07       Impact factor: 7.853

2.  Selective serotonin reuptake inhibitor use and risk of gestational hypertension.

Authors:  Sengwee Toh; Allen A Mitchell; Carol Louik; Martha M Werler; Christina D Chambers; Sonia Hernández-Díaz
Journal:  Am J Psychiatry       Date:  2009-01-02       Impact factor: 18.112

3.  Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?

Authors:  Kristin Palmsten; Soko Setoguchi; Andrea V Margulis; Amanda R Patrick; Sonia Hernández-Díaz
Journal:  Am J Epidemiol       Date:  2012-03-22       Impact factor: 4.897

Review 4.  Cellular stress mechanisms of prenatal maternal stress: Heat shock factors and oxidative stress.

Authors:  Jonathan Dowell; Benjamin A Elser; Rachel E Schroeder; Hanna E Stevens
Journal:  Neurosci Lett       Date:  2019-07-09       Impact factor: 3.046

5.  Depression in pregnancy is associated with preexisting but not pregnancy-induced hypertension.

Authors:  Wayne J Katon; Joan E Russo; Jennifer L Melville; Jodie G Katon; Amelia R Gavin
Journal:  Gen Hosp Psychiatry       Date:  2011-11-03       Impact factor: 3.238

6.  Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension.

Authors:  Mary A De Vera; Anick Bérard
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

7.  Pregnancy, perinatal and postpartum complications as determinants of postpartum depression: the Rhea mother-child cohort in Crete, Greece.

Authors:  K Koutra; M Vassilaki; V Georgiou; A Koutis; P Bitsios; M Kogevinas; L Chatzi
Journal:  Epidemiol Psychiatr Sci       Date:  2016-12-22       Impact factor: 6.892

8.  Antidepressant medication use, depression, and the risk of preeclampsia.

Authors:  Lyndsay Ammon Avalos; Hong Chen; De-Kun Li
Journal:  CNS Spectr       Date:  2015-02       Impact factor: 3.790

Review 9.  Could use of Selective Serotonin Reuptake Inhibitors During Lactation Cause Persistent Effects on Maternal Bone?

Authors:  Samantha R Weaver; Laura L Hernandez
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-03-30       Impact factor: 2.673

10.  Prevalence of postpartum depression and associated factors among women in Mbarara and Rwampara districts of south-western Uganda.

Authors:  Catherine Atuhaire; Godfrey Zari Rukundo; Grace Nambozi; Joseph Ngonzi; Daniel Atwine; Samuel Nambile Cumber; Laura Brennaman
Journal:  BMC Pregnancy Childbirth       Date:  2021-07-12       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.